218 related articles for article (PubMed ID: 29080225)
1. Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients.
Tyagi P; Motley SS; Koyama T; Kashyap M; Gingrich J; Yoshimura N; Fowke JH
Prostate; 2018 Jan; 78(1):17-24. PubMed ID: 29080225
[TBL] [Abstract][Full Text] [Related]
2. Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
Tyagi P; Motley SS; Kashyap M; Pore S; Gingrich J; Wang Z; Yoshimura N; Fowke JH
Int Urol Nephrol; 2015 Jul; 47(7):1051-8. PubMed ID: 25924782
[TBL] [Abstract][Full Text] [Related]
3. Does Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms.
Fowke JH; Koyama T; Fadare O; Clark PE
PLoS One; 2016; 11(6):e0156918. PubMed ID: 27336586
[TBL] [Abstract][Full Text] [Related]
4. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
5. [FEATURES OF CLINICAL COURSE AND MORPHOMETRIC PARAMETERS OF BENIGN PROSTATIC HYPERPLASIA IN MEN WITH METABOLIC SYNDROME AND ANDROGEN DEFICIENCY].
Tyuzikov IA; Grekov EA; Kalinchenko SY
Urologiia; 2015; (5):66-9. PubMed ID: 26859941
[TBL] [Abstract][Full Text] [Related]
6. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
8. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
[TBL] [Abstract][Full Text] [Related]
9. Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients.
Lee SH; Kim JC; Lee JY; Kim JH; Oh CY; Lee SW; Yoo SJ; Chung BH
J Sex Med; 2009 Aug; 6(8):2292-8. PubMed ID: 19493291
[TBL] [Abstract][Full Text] [Related]
10. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
[TBL] [Abstract][Full Text] [Related]
11. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
12. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
[TBL] [Abstract][Full Text] [Related]
13. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
[TBL] [Abstract][Full Text] [Related]
14. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
Lee JH; Kwon H; Park YW
Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
[TBL] [Abstract][Full Text] [Related]
15. Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.
Robert G; Descazeaud A; Nicolaïew N; Terry S; Sirab N; Vacherot F; Maillé P; Allory Y; de la Taille A
Prostate; 2009 Dec; 69(16):1774-80. PubMed ID: 19670242
[TBL] [Abstract][Full Text] [Related]
16. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
17. Effects of prostatic inflammation on LUTS and alpha blocker treatment outcomes.
Lee HN; Kim TH; Lee SJ; Cho WY; Shim BS
Int Braz J Urol; 2014; 40(3):356-66. PubMed ID: 25010301
[TBL] [Abstract][Full Text] [Related]
18. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
[TBL] [Abstract][Full Text] [Related]
19. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC; Elhilali M; Vallancien G;
BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
[TBL] [Abstract][Full Text] [Related]
20. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
